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Abstract
In the development of psychotic symptoms, environmental and genetic factors may both play a role. The reported
association between childhood trauma and psychotic symptoms could therefore be moderated by single nucleotide
polymorphisms (SNPs) associated with the stress response, such as FK506-binding protein 5 (FKBP5) and brain-derived
neurotrophic factor (BDNF). Recent studies investigating childhood trauma by SNP interactions have inconsistently found
the hippocampus to be a potential target underlying these interactions. Therefore, more detailed modelling of these effects,
using appropriate covariates, is required. We examined whether BDNF/FKBP5 and childhood trauma interactions affected
two proxies of hippocampal integrity: (i) hippocampal volume and (ii) cognitive performance on a block design (BD) and
delayed auditory verbal task (AVLT). We also investigated whether the putative interaction was different for patients with a
psychotic disorder (n = 89) compared to their non-psychotic siblings (n = 95), in order to elicit possible group-specific
protective/vulnerability effects. SNPs were rs9296158, rs4713916, rs992105, rs3800373 (FKBP5) and rs6265 (BDNF). In the
combined sample, no BDNF/FKBP5 by childhood trauma interactions were apparent for either outcome, and BDNF/FKBP5
by childhood trauma interactions were not different for patients and siblings. The omission of drug use and alcohol
consumption sometimes yielded false positives, greatly affected explained error and influenced p-values. The consistent
absence of any significant BDNF/FKBP5 by childhood trauma interactions on assessments of hippocampal integrity suggests
that the effect of these interactions on psychotic symptoms is not mediated by hippocampal integrity. The importance of
appropriate statistical designs and inclusion of relevant covariates should be carefully considered.
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Introduction
A history of childhood trauma (CT) is prevalent in individuals
suffering from psychotic symptoms [1,2]. The observation that
cessation of CT is associated with reduced psychotic symptoms [2]
provides further speculation for a link between the two. Although
recent studies have attempted to investigate interplay between CT
and genetic variation in relation to psychotic symptoms later in life
[3,4], the underlying neurobiology mediating these effects remains
poorly understood [5].
Exposure to CT/abuse has been reported to affect hypothal-
amus-pituitary-adrenal axis (HPA) function later in life: changes in
cortisol [6] and adrenocorticotropin hormone [6,7] release have
been observed. At the structural level, the hippocampus has been
shown to be particularly sensitive to stress hormone exposure,
supported by reductions in neurogenesis [8] and increased atrophy
[9]. This finding goes hand in hand with reports of hippocampal
volume being decreased in some, but not all, clinical [10] and non-
clinical [11] samples that experienced CT. The underlying
mechanism behind this decrease may be that significant stress
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triggers an increase in levels of circulating glucocorticoids [9].
Excessive levels of glucocorticoids negatively affect dendritic
branching [12] and neurogenesis [13] specifically in the hippo-
campus [9]. Given that hippocampal-dependent memory systems
develop relatively late [14], this may have deleterious effects on
hippocampal-dependent memory maturation and underlying
functions later in life.
FK506-binding protein 5 (FKBP5) gene [4] and brain-derived
neurotrophic factor (BDNF) messenger ribonucleic acid (mRNA)
[3] are expressed in the hippocampus [15,16], impact on
hippocampal functioning [17] and are associated with the stress
response [4,18,19], suggesting that genetic variation in FKBP5
and BDNF may affect hippocampal morphology and function,
potentially contributing to differential sensitivity to CT between
individuals.
Studies that have investigated the effect of either CT
[10,11,20,21] or genetic variation [40] on hippocampal volume
have produced mixed results and were unable to affirm an effect
respectively. Furthermore, recent inconsistencies between studies
investigating BDNF genetic variance by CT interactions on
hippocampal volume [22,23] make it difficult to interpret the
effects of these interactions on the hippocampus, if any it all, and
therefore warrant further investigation. These inconsistent results
may be related to inappropriate use of covariates in Gene times
Environment (G6E) studies [24]: whereas G6E studies should
include relevant covariates, the covariate6 environment (E) and
covariate6 gene (G) interactions are often left out of the model.
Although these G6E are expected to be subtle, CT by genetic
variance interactions on hippocampal volume in the context of
psychosis could result in valuable insights into stress-sensitivity.
To date, two studies have investigated the effect of BDNF/
FKBP5 by CT interactions on psychotic symptoms in adulthood
[3,4]. These studies investigated single nucleotide polymorphisms
(SNPs) with functional properties within the FKBP5 [4] and
BDNF gene [3] associated with glucocorticoid receptor sensitivity
[18] and neurogenesis/neuroplasticity respectively [25,26]. Collip
and colleagues [4] showed in a general population sample that
minor alleles of FKBP5 SNPs rs9296158 and rs4713916, in
combination with exposure to CT, were associated with increased
levels of psychotic symptoms and blunted cortisol levels in
adulthood. These FKBP5 genotype by trauma interactions were
also found in different follow-up samples at different levels of
psychosis severity and familial liability, although not always
consistently so [4]. A recent study [27] demonstrated that the
risk for post-traumatic stress disorder is associated with FKBP5
genotype-specific CT-dependent demethylation, in support of
FKBP5 genotype by CT interactions in the development of stress-
related disorders later in life. Alemany and colleagues [3] showed
that the expression of subclinical psychosis in a general population
sample was dependent on BDNF Val66Met genotype in those
exposed to CT, a finding that remains to be replicated in
independent samples [5]. So far, the effect of BDNF/FKBP5 by
CT interactions on hippocampal volume in the context of
psychosis has not been investigated. Given the presence of such
interactions on the behavioural (i.e. symptom level) [3,4], such
interactions might indicate subtle changes in hippocampal
structure or function in psychosis.
The present study investigated whether synergistic effects of CT
and BDNF/FKBP5 genotype influenced two proxies of hippo-
campal integrity in a large sample of individuals with psychotic
disorder and siblings. These proxies were: (i) assessments of
hippocampal volume and (ii) delayed performance on an auditory
verbal learning task and performance on a spatial memory task,
cognitive tasks consistently demonstrated to be dependent on
hippocampal function [28–30]. Decreased hippocampal integrity,
negative changes in the structure’s function, would potentially be
reflected in attenuated volume and decreased cognitive perfor-
mance.
We first investigated the role of BDNF and FKBP5 in the
association between CT and hippocampal volume/cognitive
performance in adulthood, regardless of illness status, further
investigating recent mixed results on the role of the BDNF gene in
the association between childhood adversity and hippocampal
volume [22,23]. Given that not all individuals who experience CT
develop a psychotic disorder, we further investigated whether the
effect of BDNF/FKBP5 SNP genotype on the association between
CT and hippocampal volume/cognitive performance was different
for patients and their siblings, in order to elicit possible group-
specific protective/vulnerability effects. Covariate6E and G were
included in all relevant analyses. Model fit tests were performed and
covariates associated with hippocampal volume were included.
Methods
Sample
All data described in this manuscript pertain to a longitudinal
magnetic resonance imaging (MRI) study in Maastricht, the
Netherlands [31]). Data from 89 patients with a psychotic disorder
and 95 healthy non-psychotic siblings of patients with a psychotic
disorder were used for the analyses described in this manuscript.
Siblings and patients were compared as they are i) genetically
more alike and ii) share more environmental variance than
controls and patients [32]. The statistical power of case-sib designs
in G6E studies may be greater than case-control designs when the
correlation with E is low to moderate [32,33], which is the case in
the current study [1]. Furthermore, case-sibling designs are
insensitive to population stratification bias and eliminate environ-
mental/genetic confounders associated with unrelated controls
[32]. Patients were recruited through representative clinicians
whose caseload was screened for inclusion criteria. Siblings were
sampled through participating patients. For 51 families, two or
more participants took part in the study (2 participants (n = 46), 3
participants (n = 4), 4 participants (n = 1)). The composition of
participants from one family was as follows: 1 sibling and 1 patient
(n = 39), 2 siblings (n = 4), 2 patients (n = 3), 3 siblings (n = 1), 2
siblings and 1 patient (n = 3), 3 siblings and 1 patient (n = 1).
Diagnoses were based on DSM-IV criteria, using the Compre-
hensive Assessment of Symptoms and History (CASH) interview
[34]. Patient diagnoses were: schizophrenia (n = 69), brief
psychotic disorder (n = 2), psychotic disorder not otherwise
specified (n = 18). The CASH was additionally used to confirm
the absence of non-affective psychosis in siblings [31]. Exclusion
criteria were: I) brain injury with loss of consciousness.1 hour, II)
meningitis/other neurological diseases, III) cardiac arrhythmia,
IV) severe claustrophobia, V) metal corpora aliena (including
intrauterine devices) VI) pregnancy. The ethics committee of the
faculty of health, medicine and life science of Maastricht
University approved the study. Written informed consent was
obtained from every participant before participating in the study.
All participants included in the study were able to give informed
consent without the use of a legal representative or guardian.
MRI
MRI acquisition. MRI scans were obtained on a 3T
Siemens scanner (Erlangen, Germany). Acquisition parameters:
Modified Driven Equilibrium Fourier Transform (MDEFT)
sequence with 176 slices, isotropic voxel size of 1 mm, echo
time= 2.4 ms, repetition time= 7.92 ms, inversion time= 910 ms,
Hippocampus Not Affected by BDNF/FKBP5 x Trauma
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flip angle = 15u, total acquisition time= 12 m51 s. Magnetization
Prepared Rapid Acquisition Gradient-Echo (MPRAGE) sequence
with 192 slices, isotropic voxel size of 1 mm, echo time=2.6 ms,
repetition time= 2250 ms, inversion time= 900 ms, flip angle =
9u, total acquisition time= 7 m23 s. Matrix size was 2566256 and
field of view was 2566256 mm2. The number of excitations was
one. Two sequences were used because of a scanner update during
data collection. The MPRAGE and MDEFT are similar, but to
prevent any systematic bias, the total proportion of MPRAGE
scans (approximately one third) was balanced between the groups
[31].
MRI preprocessing and volume measures. Preprocessing
was performed and structural volumetric measures were obtained
using reconstruction and volumetric segmentation procedures
from the freely available Freesurfer stable release version v5.0.0
(http://surfer.nmr.mgh.harvard.edu/), published in detail previ-
ously [11] and running on a Macintosh with OSX 10.6.4. In short,
volumetric assessments of the left and right hippocampus were
obtained for all participants using automatic classification proce-
dures and labeling [35]. The FreeSurfer processing pipeline
automatically assigns a neuroanatomical label, roughly corre-
sponding to each voxel in an MRI volume (after partial volume
correction), based on probabilistic information estimated from a
manually labeled training set. The accurate labeling of subcortical
structures is achieved through the use of both global and local
information. The global information is based on an atlas that
makes the labeling robust to contrast properties of the anatomical
structures. Modeling the classification as a non-stationary aniso-
tropic Markov random field incorporates local information. The
introduction of non-stationary and anisotropy into the classical
Markov random field model allows spatial relationships of
anatomical classes to enter into the segmentation procedure. For
instance, the probability that a voxel labeled ‘‘hippocampus’’ will
have its inferior neighbor labeled as amygdala provides a strong set
of spatial constraints. The output that FreeSurfer yields is rounded
off to an integer number and therefore reflects the number of
voxels in an area. The technique has previously been shown to be
comparable in accuracy to manual labeling [35]. The segmenta-
tions were visually inspected for accuracy. A measure of
intracranial volume (all voxels in a brain) was also generated, by
adding up voxel counts for each area.
Childhood Trauma
CT was assessed with the Dutch version of the Childhood
Trauma Questionnaire Short Form (CTQ). The short CTQ
consists of 25 items rated on a 5-point Likert scale (1 = never true
to 5 = very often true) inquiring about traumatic experiences in
childhood. Five types of childhood maltreatment were assessed:
emotional (mean= 1.6, sd = .77), physical (mean= 1.2, sd = .55)
and sexual abuse (mean=1.19, sd = .53), and emotional
(mean=2.1, sd = .84) and physical neglect (mean= 1.36,
sd = .49). Five questions covered each type of trauma [36].
Calculating the mean of the 25 items resulted in a general measure
of CT. CTQ data were missing for 9 participants (4.9%)
(siblings = 4, patients = 5).
Cognitive performance
Two neuropsychological tasks that rely on hippocampal
functioning were included: the auditory verbal learning task
(AVLT) and block design (BD) task, part of the Dutch version of
the Wechsler Adult Intelligence Scale (WAIS IV). Delayed
performance on the AVLT and BD performance assess recall
capacity and spatial memory respectively, processes dependent on
hippocampal integrity [28–30]. Delayed AVLT performance was
defined as the number of words successfully recalled after a 15-
minute interval (after a 15-word list was repeated three times). BD
raw scores were calculated as the total amount of points after 14
trials. The task was ended prematurely when the participant
scored no points on four consecutive trials. Depending on their
speed, participants scored between zero and two points on each of
the first six trials and between four to seven points on the
remaining trials. AVLT and BD data were unavailable for 9,8% of
the sample (16 siblings, 2 patients). AVLT performance was
normally distributed. BD scores were exponentiated, after which
they were normally distributed.
Genes
The FKBP5 SNP selection was based on previous work [4]
revealing an interaction between FKBP5 SNPs rs9296158,
rs4713916, rs992105, rs3800373 and CT in the model of
psychotic symptoms and cortisol levels later in life. BDNF SNP
rs6265 (Val66Met) was selected on the basis of a reported
interaction between rs6265 and CT in the context of psychotic
symptoms later in life [3]. BDNF is a functional SNP (http://www.
ncbi.nlm.nih.gov/gene/627) and selected FKBP5 SNPs have been
consistently associated with functional outcomes [4,18,37,38].
Genomic DNA was collected from blood. SNPs were determined
by Sequenom (Hamburg, Germany), using the Sequenom
MassARRAY iPLEX platform at the facilities of the manufactur-
er. The distribution of SNPs (among groups) is presented in Table
S1. The selected SNPs were in Hardy-Weinberg equilibrium:
rs9296158 (x2 = 2.34, p = .18), rs4713916 (x2 = .06, p = .83),
rs992105 (x2 = .03, p = .73), rs3800373 (x2 = .35, p = .68) and
rs6265 (x2 = .87, p= .32). The distribution of genotypes among
groups was not significantly different: rs9296158 (x2 = .99, p = .61),
rs4713916 (x2 = .73, p = .69), rs992105 (x2 = 2.93, p = .23),
rs3800373 (x2 = .2.88, p = .24) and rs6265 (BDNF) (x2 = 1.14,
p = 0.57). The linkage disequilibrium (LD) between FKBP5 SNPs
has been described previously [4]. None of the selected FKBP5
SNPs were in 100% LD. No significant differences in demographic
variables (table 1 for variables) on the basis of SNP genotype were
observed (data available upon request).
Antipsychotic medication use
Antipsychotic medication use was determined by multiplying
the number of days of antipsychotic medication use with the
corresponding haloperidol equivalents and summing scores for all
periods of antipsychotics use (including the exposure period
between baseline assessment for the study and moment of MRI
scan), using the published converting formulas for antipsychotic
medication dose equivalents described by Andreasen and
colleagues’ [39]. 11 patients used antidepressants.
Analyses
For hippocampal volume, the number of voxels in the left and
right hippocampus was used as continuous dependent variable, an
indication of the structure’s size. For cognitive performance, we
used delayed AVLT and (exponentiated) BD performance as a
continuous measure. The effect of group (patients vs. siblings;
categorical), genotype (BDNF/FKBP5 genotype; categorical) and
CT (total CTQ score; continuous) on hippocampal volume/
cognitive performance was first explored separately. Association
analyses between hippocampal volume and antipsychotic medica-
tion use were also performed. Next, we investigated the role of
BDNF/FKBP5 genotype in the association between CT and
hippocampal volume/cognitive performance in adulthood in the
whole sample (hippocampal volume/cognitive performance =
genotype*CT), guided by recent mixed results on the role of the
Hippocampus Not Affected by BDNF/FKBP5 x Trauma
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BDNF gene in the association between childhood adversity and
hippocampal volume [22,23]. We then investigated whether the
variable ‘‘group’’ (patients, siblings) moderated the association
between CT and hippocampal volume/cognitive performance.
Finally, it was investigated whether ‘‘group’’ moderated the effect
of BDNF/FKBP5 genotype in the association between CT and
hippocampal volume/cognitive performance (hippocampal vol-
ume/cognitive performance = genotype*CT*group). For this
analysis, group was added as an independent variable (section 3.3).
Given the low number of homozygous minor allele carriers (Table
S1), risk allele carriers were grouped for genetic analyses [major
allele homozygotes = [1], minor allele heterozygotes and homozy-
gotes = [2]).
Statistical model, covariates and software
Demographic analyses were performed using linear regression
and chi-square tests (REGRESS and TAB command in STATA
11.0 respectively). All remaining regression analyses were mixed
models and were performed using the XTMIXED command in
Stata 11.0 (StataCorp LP, College Station, TX, 2013) with family
ID as random effect [31]. Cannabis use (scale, lifetime) [40,41],
other drug use (scale, lifetime) [42] and alcohol consumption [43]
were assessed using the Composite International Diagnostic
Interview (WHO, 1990). Cannabis use and other drug use were
scored on 8-point scales (1 = 1–5 times, 2 = 6–9, 3= 10–19,
4 = 20–39, 5 = 40 – 59, 6 = 60–79, 7 = 80–99, 8 =.100)). These
two scales were averaged per person to create a ‘‘drug use’’
covariate.
Volumetric analyses were corrected for intracranial volume,
age, gender [22,23], educational level (8-point scale that ranged
from primary school (1) to master’s degree (8)), drug use and
alcohol consumption (drug use and alcohol consumption hereafter:
‘‘substance use’’). AVLT and BD analyses were corrected for age,
gender and substance use. AVLT and BD analyses were not
corrected for educational level because of their high collinearity.
The Bonferroni-corrected threshold for genotype analyses was
p= .005 (10 tests; 5 SNPs6 left and right hippocampal volume/
AVLT and BD performance). Covariate6E and covariate6G
were included in every G6E analysis [24]. Covariate 6 E and
covariate6G were included in G and E interactions respectively.
Model fit tests, using a two-tailed likelihood ratio test, were
performed to select the optimal statistical model and demonstrate
the effect of relevant covariates on model fit. Although the
scantype (mdeft/adni) was equally distributed among groups, all
analyses were repeated with scantype as covariate. Adding
scantype as a covariate did not affect the (non-)significance of
any of the results. Adding antidepressant use as a covariate also did
not affect the outcomes. CT analyses were repeated using a
dichotomized variable (dichotomized at the 80th percentile of the
trauma scores of controls; see Heins et al[1]), but did this not affect
the results.
Results
Demographics and main effects
Demographics. Demographics are shown in table 1. Patients
differed from siblings on education, cannabis use, use of other
drugs (patients.siblings) and alcohol consumption (patients,
siblings). Education, cannabis and other drug (as ‘‘drug use’’) were
therefore included in all relevant analyses (next to age, gender and
intracranial volume) (see also section 2.8).
Model choice. Given that groups differed on some socio-
demographic variables (e.g. drug use) (table 1), model fit tests were
performed to determine the optimal statistical model. Model fit
was assessed using likelihood ratio tests (Likelihood ratio = 22
ln(L(model1)/L(model2)) = 2(ll(model2)-ll(model1))). This ratio
test yielded a chi-square statistic and p-value, with significant p-
values indicating that model 2 (special case of model 1) fits the data
better. For both hippocampal volume and cognitive performance,
a model including substance use (in addition to intracranial
volume (volumetric analyses only), age and gender) provided a
significantly better model fit than a model without substance use at
all levels (Table S2). More parsimonious models (i.e. leaving one of
the substance use variables out of the model) did not provide
systematic improvements in model fit at all levels (data not shown).
Therefore, a model including all substance use items (alcohol, drug
Table 1. Sociodemographic variables for individuals with a diagnosis of psychotic disorder and healthy siblings.
Siblings (n =95) Patients (n=89) Statistic p
Age, mean (SD) 29.66 (8.79) 28.08(7.04) 21.331 .18
Gender, n (%) 5.072 .02
male 50 (53%) 60 (69%)
Alcohol past 12 months (units/week), mean (SD) 9.77 (17.1) 4.85 (8.97) 22.281 .02
Cannabis use past lifetime3 (count), mean (SD) 2.38 (2.61) 4.24 (3.24) 4.21 ,.01*
Other drug use lifetime3 (count), mean (SD) 1.38 (1.3) 2.7 (2.78) 4.151 ,.01*
Education4 (finished), mean (SD) 5.11 (2.04) 4.28 (1.98)
Childhood Trauma Questionnaire total score, mean (SD) 6.88 (1.66) 8.16 (2.81) 3.731 ,.01*
Lifetime Haldol equivalents, mean (SD) 6866.68 (6153.07) 22.73 ,.01*
Scan type (MDEFT, ADNI), n (%) 2 .16
MDEFT 59 (62%) 45 (52%)
1t-value
2X2-value
*p,.05
3Cannabis and other drug values ranged from 1–8 (1 = 1–5 times, 2 = 6–9, 3 = 10–19, 4 = 20–39, 5 = 40 – 59, 6 = 60–79, 7 = 80–99, 8 =.100)
4Education ranged from 1 (primary school) to master’s degree (8)
MDEFT = Modified Driven Equilibrium Fourier Transform
MPRAGE = Magnetization Prepared Rapid Acquisition Gradient-Echo.
doi:10.1371/journal.pone.0092722.t001
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use), added as separate variables, was used for all analyses reported
below.
Main effects. A strong group difference was found in left
hippocampal volume (patients,siblings) (table 2), which remained
significant after controlling for substance use. No significant
association between SNP genotype (BDNF/FKBP5) and hippo-
campal volume was observed (model including substance use: p-
values ranging from.22 to.93, data not shown), and the same held
true for the association between CT and hippocampal volume
(table 2). Siblings performed better on the delayed AVLT task,
only when substance use was included. Siblings only performed
better on the BD task than patients when substance use included in
the model (table 2). No association between BDNF/FKBP5
genotype and delayed AVLT (model including substance use: p-
values ranged from.07 to.66, data not shown) or BD performance
(model including substance use: p-values ranged from.19 to.61
data not shown) was observed, even when omitting substance use.
Higher levels of CT were negatively associated with BD
performance, even when substance use was excluded from the
model (table 2). CT was not associated with AVLT performance.
CT was positively associated with drug use, but not with alcohol
consumption (table 1). Substance use was not associated with
genotype (data not shown).
Medication. Best-estimates of lifetime cumulative antipsy-
chotic medication use were not associated with left or right
hippocampal volume in patients (left: B=,.01, Z= ..69, 95%
CI=2.01 –.02, p= .49; right: B,.01, Z= .36, 95% CI=2.012 –
.017, p= .72). No association between lifetime cumulative antipsy-
chotic medication and delayed AVLT (B,.01, Z= .68, 95% CI=0
– ,.01, p= .49) or BD performance (B,2.02, Z=2.86, 95%
CI=2.07 –.03, p= .39) was observed.
The role of group/genotype in the association between
childhood trauma and hippocampal volume/cognitive
performance
Hippocampal volume. Convincing CT by group interac-
tions in the model of left and right hippocampal volume were not
observed (left: B= 275.36, Z=21.9, 95% CI= 2152.912 2.18,
p= .06; right: B=267.17, Z=21.82, 95% CI= 2145.16 – 19.41,
p= .13), even when substance use was included (left: B= 265.64,
Z=21.84, 95% CI= 2135.59 – 4.3, p= .07; right: B= 272.88,
Z=21.86, 95% CI=2149.83 – 4.08, p= .06). Variations within
the selected FKBP5 SNPs, rs9296158, rs4713916, rs992105,
rs3800373 and BDNF did not significantly interact with CT to
influence hippocampal volume (table 3: model including substance
use), regardless of the addition of substance use to the model.
Cognitive performance. CT and group did not interact in
the model of delayed AVLT/BD performance (model including
substance use: AVLT: B=2.14, Z=2.52, 95% CI= 2.66 –.38,
p = .6; BD: B= 249.5, Z=2.39, 95% CI= 2299.57 – 200.57,
p = .7), regardless of substance use. Variations within rs9296158,
rs4713916, rs992105, rs3800373 and BDNF did not interact with
CT in the model of AVLT/BD performance (table 4: model
including substance use), regardless of substance use.
The moderating role of BDNF/FKBP5 SNP genotype in
the association between childhood trauma and
hippocampal volume/cognitive performance
Hippocampal volume. No evidence for group X FKBP5 X
CT interactions was observed for hippocampal volume (table 5:
model including substance use) when substance use was added to
the model. When substance use was omitted, there was a trend-
significant BDNF6CT6group interaction for left hippocampal
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volume at the p(corrected) threshold of.005 (left: B = 215.47,
Z= 2.35, 95% CI= 35.55 – 395.39, p = .02; right: B = 143.83,
Z= 1.47, 95% CI= 248.57 – 336.23, p= .14). This tentative
interaction indicated the following: CT decreased left hippocam-
pal volume in sibling Met-allele carriers (relative to sibling Val
homozygotes), while CT increased left hippocampal volume in
patient Met-allele carriers (relative to patient Val homozygotes).
Cognitive performance. No evidence for group6FKBP5/
BDNF 6 CT interactions in the model of delayed AVLT/BD
performance was observed (table 6: model including substance
use).
Discussion
We investigated whether FKBP5 and BDNF genotype moder-
ated the association between CT and two proxies of hippocampal
integrity differently in individuals with a diagnosis of a psychotic
disorder, compared to healthy siblings. We presented evidence
that hippocampal volume and cognitive performance (on a
delayed AVLT and BD task) were not affected by a BDNF/
FKBP5, CT and group status interaction, at least, when
adequately controlling for the undesired influence of drug use
and alcohol consumption.
The moderating effects of genes on the association
between childhood trauma and hippocampal volume
BDNF and FKBP5 genotype did not moderate the association
between CT and hippocampal volume assessed later in life,
regardless of group status. This is the first investigation looking at
FKBP5 genotype by CT interactions in the model of hippocampal
volume. Our BDNF findings parallel those of a recent study [23],
who also did not observe a significant BDNF genotype by
childhood adversity interaction on, among others, hippocampal
volume in a large sample of healthy volunteers screened for a past
of illicit drug and other substance use. Similarly, no differences in
levels of hippocampal BDNF gene expression were observed in
maltreated and control rats in an animal model of childhood
Table 3. FKBP5 and BDNF SNP genotype do not affect the association between childhood trauma and hippocampal volume (no
group).
SNP Area B 95% CI Z p
rs9296158 L HC 61.43 257.31 to 180.17 1.01 .31
R HC 62.26 258.1 to 182.62 1.01 .31
rs4713916 L HC 47.73 238 to 133.45 1.09 .28
R HC 49.33 237.42 to 136.08 1.11 .27
rs992105 L HC 48.14 249.07 to 145.36 .97 .33
R HC 63.78 235.24 to 162.8 1.26 .21
rs1360780 L HC 27.72 295.48 to 80.04 2.17 .86
R HC 13.74 276.14 to 103.62 .3 .77
BDNF (rs6265) L HC 25.82 2102.41 to 154.05 .39 .69
R HC 36.79 293.1 to 166.67 .56 .58
Group coding: sibling= [0], patient = [1]
Genotype coding: dichotomous, major allele homozygotes vs. minor allele hetero- and homozygotes (see section 2.7). Childhood trauma score: continuous.
P(corrected) = .005. Covariates: intracranial volume, age, gender, education, substance use. Random factor: family id. HC= hippocampus.
doi:10.1371/journal.pone.0092722.t003
Table 4. FKBP5 and BDNF SNP genotype do not affect the association between childhood trauma and AVLT and BD performance
(no group).
SNP Performance B 95% CI Z p
rs9296158 AVLT .38 2.33 to 1.08 1.05 .29
BD 89.42 2240.73 to 419.56 .53 .6
rs4713916 AVLT .16 2.38 to.71 .6 .55
BD 70.08 2190.91 to 331.07 .53 .6
rs992105 AVLT .54 2.1 to 1.18 1.64 .1
BD 428.55 128.17 to 728.93 2.8 ,.01
rs1360780 AVLT .27 2.26 to.8 .99 .32
BD 128.03 2130.13 to 386.19 .97 .33
BDNF (rs6265) AVLT 2.14 2.43 to –.7 .48 .63
BD 29.63 2238.56 to 297.81 .22 .83
Group coding: sibling= [0], patient = [1]
Genotype coding: dichotomous, major allele homozygotes vs. minor allele hetero- and homozygotes (see section 2.7). Childhood trauma score: continuous.
P(corrected) = .005. Covariates: age, gender, substance use. Random factor: family id.
doi:10.1371/journal.pone.0092722.t004
Hippocampus Not Affected by BDNF/FKBP5 x Trauma
PLOS ONE | www.plosone.org 6 March 2014 | Volume 9 | Issue 3 | e92722
adversity, yet differences in the prefrontal cortex (PFC) were
present [19]. These findings seemingly disagree with those of
Carballedo and colleagues [22], who observed an association
between BDNF genotype and hippocampal volume when
combining their sample of patients with depressive disorder
(MDD) and healthy controls: for a given amount of exposure to
childhood adversity, Met-allele carriers had a smaller hippocampal
volume than Val homozygotes. The results in the present study
suggest the absence of such interactions when alcohol consump-
tion and drug use are included in the model, factors that have been
demonstrated to affect brain structure [40–43]. Differences in
sample characteristics, studied populations (MDD vs. psychotic
disorder), but also relevant inclusion of covariates and their E and
G interactions [24] could explain the discrepancy in results.
No main effects of BDNF genotype on hippocampal volume
were observed, in agreement with a recent inconclusive meta-
analysis [44], although left hippocampal volume was dependent on
group status. A trend-significant group by CT by BDNF
interaction in the model of left hippocampal volume was largely
due to the confounding effects of substance use and disappeared
after adequate inclusion of covariates and their G/E interactions.
Our results indicate that assessments of hippocampal volume can
be misrepresented when not taking into account the effect of
substance use. Importantly, the provocative results we present
could partially explain why published reports on the effect of
stressful events during childhood and hippocampal volume later in
life have been mixed (positive: [10,11], inconclusive: [20,21]).
Moreover, they could justify the inclusion of relevant covariates
and careful evaluation of statistical models (e.g. model fit tests,
covariate times G/E interactions) in an attempt to discern between
true association and confounding.
Gene by childhood trauma interactions on cognitive and
affective domains
In concordance with our volumetric results, CT by BDNF/
FKBP5 genotype interactions, with or without the inclusion of
group status, were not observed in the model of delayed AVLT
Table 5. No significant effect of group (sibling, patient) on FKBP5 and BDNF SNP genotype x childhood trauma interactions in the
model of hippocampal volume.
SNP Area B 95% CI Z P
rs9296158 L HC 161.47 260.8 to 383.74 1.42 .16
R HC 204.93 224.53 to 434.39 1.75 .08
rs4713916 L HC 12.77 2175.75 to 201.3 .13 .89
R HC 21.39 2197.62 to 194.84 2.01 .99
rs992105 L HC 142.62 269.96 to 355.1 1.31 .2
R HC 95.29 2126.47 to 317.05 .84 .4
rs1360780 L HC 44 2157.1 to 245.09 .43 .67
R HC 50.82 2154.6 to 256.25 .48 .63
BDNF (rs6265) L HC 141.06 293.56 to 375.68 1.18 .24
R HC 37.82 2207.44 to 283.08 .3 .76
Group coding: sibling= [0], patient = [1]
Genotype coding: dichotomous, major allele homozygotes vs. minor allele hetero- and homozygotes (see section 2.7). Childhood trauma score: continuous.
P(corrected) = .005. Covariates: intracranial volume, age, gender, education, substance use. Random factor: family id. HC= hippocampus.
doi:10.1371/journal.pone.0092722.t005
Table 6. No significant effect of group (sibling, patient) on BDNF SNP genotype x childhood trauma interactions in the model of
AVLT and BD performance.
SNP Performance B 95% CI Z P
rs9296158 AVLT .07 21.27 to 1.41 .1 .92
BD 163.47 2496.54 to 823.48 .49 .63
rs4713916 AVLT 2.56 21.73 to.61 2.94 .35
BD 53.65 2535.89 to 643.19 .18 .86
rs992105 AVLT 2.24 21.55 to 1.06 2.37 71
BD 2108.24 2765.49 to 549 2.32 .75
rs1360780 AVLT 2.21 21.43 to 1.01 2.33 .74
BD 77.29 2525.94 to 680.52 .25 .8
BDNF (rs6265) AVLT 21.35 22.6 to.11 22.13 .03
BD 2134.33 2774.4 to 505.75 2.41 .68
Group coding: sibling= [0], patient = [1]
Genotype coding: dichotomous, major allele homozygotes vs. minor allele hetero- and homozygotes (see section 2.7). Childhood trauma score: continuous.
P(corrected) = .005. Covariates: age, gender, substance use. Random factor: family id.
doi:10.1371/journal.pone.0092722.t006
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and BD performance. The presented results are the first to
indicate that FKBP5 genotype does not affect the association
between CT (or CT by group status interactions) and hippocam-
pal-dependent cognition. Although BDNF did not influence the
association between CT interactions and cognition, BDNF
genotype has been shown to impact on the association between
sexual abuse and cognition [45]. Importantly, in the group of
individuals without sexual abuse, a type of abuse rare in our
sample (section 2.3), cognition was not dependent on BDNF
genotype [45], which is in line with the presented results. There
was no main effect of FKBP5 genotype variation on delayed
AVLT and BD performance, as was the case for BDNF.
Although studies investigating BDNF/FKBP5 by CT interac-
tions in the model of cognition are scarce, and associations
between BDNF genotype on cognition are modestly strong at best
[46], the association between CT and outcome measures in
affective domains has been reported to be dependent on FKBP5
and BDNF genotype. These studies have shown that the
experience of CT in BDNF Met allele carriers is associated with
increased levels of psychotic symptoms [3], could be related to
depressive symptoms [47] and increase the impact of life events on
bipolar illness [48], compared to Val allele carriers. Similarly,
FKBP5 minor alleles seem to amplify the negative effects of CT on
depression [49], threat-related brain activity [50], psychotic
symptoms and cortisol levels later in life [50]. Interestingly, a
study that found mixed effects of FKBP5 genotype on multiple
indexes of hippocampal structure, did find a marked association
between FKBP5 genotype and threat-related hippocampal activ-
ity, again, with the minority allele associated with heightened
activity [51].
Previously cited studies demonstrate a potential role for BDNF
and FKBP5 minority alleles in the association between CT and
changes in affective domains later in life. The absence of consistent
association with cognition, including those presented in the current
manuscript, could suggest that BDNF/FKBP5 genoype by CT
interactions impact on an affective, rather than cognitive, pathway
towards psychopathology later in life [52]. The absence of
associations with hippocampal volume, in combination with the
presence of other, widespread, changes in the stress network (e.g.
cortisol [4], threat-related brain activity [51], could suggest that
these interactions are more likely to affect a larger network, than to
impact on one brain structure in particular.
Strengths and limitations
The consistent absence of any FKBP5/BDNF genotype6CT
interactions could have been the result of a power problem (e.g.
CT by group by BDNF interaction in the model of delayed
AVLT). Although similar in sample size to other published work
[22], complex interactions such as the one reported under section
3.3 are generally investigated in much larger samples. Although it
is unlikely that the study was underpowered for main effects and
two-way interactions, the absence of three-way interactions should
be interpreted with caution and replicated in larger samples.
Moreover, the data presented in this manuscript are cross-
sectional. Conclusions drawn from these results do not imply
causality and can not answer questions with regard to the temporal
association between CT, hippocampal volume and cognition.
Furthermore, CT was retrospectively assessed in this study, which
could have lead to over- or underestimations of the actual
prevalence and impact of CT. It is also unlikely that the genes
investigated in the current study are solely responsible for G6E in
the context of CT and psychosis. Although genes were a-priori
selected, based on previous evidence [3,4], polygenic risk scores or
the incorporation of multiple genes associated with the human
stress response might have uncovered more subtle G6E interac-
tions that were not observed in the current study.
In order to provide an accurate reflection of hippocampal
integrity, two proxies were investigated. The degree of consistency
between those results may have benefitted the accuracy of the
conclusions. Furthermore, including influential sample character-
istics (genetic, environmental, demographic and lifestyle factors)
and the use of appropriate covariates (times G/E) [24] may have
attributed to the validity of the results. Finally, we compared
individuals at above average genetic risk, siblings, with a patient
sample. These two groups may be genetically more alike, share
more environmental variance and therefore more easily compared
than controls and patients, who are environmentally and
genetically less alike [32].
Data presented in this manuscript is available to collaborators
upon request.
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